Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Reply to: Patients with COPD Require more than Pulmonary Rehabilitation to Improve Outcomes.

Nici L, Singh SJ, Holland AE, ZuWallack RL.

Am J Respir Crit Care Med. 2019 Jul 29. doi: 10.1164/rccm.201907-1383LE. [Epub ahead of print] No abstract available.

PMID:
31355668
2.

Opportunities and Challenges in Expanding Pulmonary Rehabilitation into the Home and Community.

Nici L, Singh SJ, Holland AE, ZuWallack RL.

Am J Respir Crit Care Med. 2019 Oct 1;200(7):822-827. doi: 10.1164/rccm.201903-0548PP. No abstract available.

PMID:
31051091
3.

Pulmonary rehabilitation for bronchiectasis: if not now, when?

Metersky ML, ZuWallack RL.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802474. doi: 10.1183/13993003.02474-2018. Print 2019 Jan. No abstract available.

PMID:
30655455
4.

Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries.

Spitzer KA, Stefan MS, Priya A, Pack QR, Pekow PS, Lagu T, Pinto-Plata VM, ZuWallack RL, Lindenauer PK.

Ann Am Thorac Soc. 2019 Jan;16(1):99-106. doi: 10.1513/AnnalsATS.201805-332OC.

PMID:
30417670
5.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Spruit MA, Singh SJ, Rochester CL, Greening NJ, Franssen FME, Pitta F, Troosters T, Nolan C, Vogiatzis I, Clini EM, Man WD, Burtin C, Goldstein RS, Vanfleteren LEGW, Kenn K, Nici L, Janssen DJA, Casaburi R, Shioya T, Garvey C, Carlin BW, ZuWallack RL, Steiner M, Wouters EFM, Puhan MA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701312. doi: 10.1183/13993003.01312-2017. Print 2018 Jan. No abstract available.

6.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

7.

Integrating the care of the complex COPD patient.

Donner CF, Carrozzi L, Maio S, Baldacci S, Pistelli F, Viegi G, Purro A, Torchio R, Clini E, Amaducci S, ZuWallack RL, Goldstein R, Morgan M, Bourbeau J, Vagheggini G, Wouters EFM.

Monaldi Arch Chest Dis. 2017 May 18;87(1):786. doi: 10.4081/monaldi.2017.786.

8.

An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation.

Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, Spruit MA, Masefield S, Casaburi R, Clini EM, Crouch R, Garcia-Aymerich J, Garvey C, Goldstein RS, Hill K, Morgan M, Nici L, Pitta F, Ries AL, Singh SJ, Troosters T, Wijkstra PJ, Yawn BP, ZuWallack RL; ATS/ERS Task Force on Policy in Pulmonary Rehabilitation.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86. doi: 10.1164/rccm.201510-1966ST.

PMID:
26623686
9.

Pulmonary Rehabilitation and Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.

Spruit MA, Pitta F, McAuley E, ZuWallack RL, Nici L.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):924-33. doi: 10.1164/rccm.201505-0929CI. Review.

PMID:
26161676
10.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.

11.

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.

PMID:
25830527
12.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir J. 2015 Apr;45(4):879-905. doi: 10.1183/09031936.00009015. Review.

13.

Preface.

Nici L, ZuWallack RL.

Clin Chest Med. 2014 Jun;35(2):xiii. doi: 10.1016/j.ccm.2014.03.001. Epub 2014 Apr 12. No abstract available.

PMID:
24874139
14.

Pulmonary rehabilitation: future directions.

Nici L, ZuWallack RL.

Clin Chest Med. 2014 Jun;35(2):439-44. doi: 10.1016/j.ccm.2014.02.015. Epub 2014 Apr 12. Review.

PMID:
24874138
15.

Pulmonary rehabilitation: definition, concept, and history.

Nici L, ZuWallack RL.

Clin Chest Med. 2014 Jun;35(2):279-82. doi: 10.1016/j.ccm.2014.02.008. Epub 2014 Apr 12. Review.

PMID:
24874123
16.

Differences in content and organisational aspects of pulmonary rehabilitation programmes.

Spruit MA, Pitta F, Garvey C, ZuWallack RL, Roberts CM, Collins EG, Goldstein R, McNamara R, Surpas P, Atsuyoshi K, López-Campos JL, Vogiatzis I, Williams JE, Lareau S, Brooks D, Troosters T, Singh SJ, Hartl S, Clini EM, Wouters EF; ERS Rehabilitation and Chronic Care, and Physiotherapists Scientific Groups; American Association of Cardiovascular and Pulmonary Rehabilitation; ATS Pulmonary Rehabilitation Assembly and the ERS COPD Audit team.

Eur Respir J. 2014 May;43(5):1326-37. doi: 10.1183/09031936.00145613. Epub 2013 Dec 12.

17.

Learn from the past and create the future: the 2013 ATS/ERS statement on pulmonary rehabilitation.

Singh SJ, ZuWallack RL, Garvey C, Spruit MA; American Thoracic Society/European Respiratory Society Task Force on Pulmonary Rehabilitation.

Eur Respir J. 2013 Nov;42(5):1169-74. doi: 10.1183/09031936.00207912. No abstract available.

18.

Measuring unsupported arm lifts as an outcome in pulmonary rehabilitation of chronic obstructive pulmonary disease patients.

Datta D, ZuWallack RL.

Chron Respir Dis. 2013 Aug;10(3):159-63. doi: 10.1177/1479972313497371.

PMID:
23897931
19.

Comprehensive pulmonary rehabilitation results in clinically meaningful improvements in anxiety and depression in patients with chronic obstructive pulmonary disease.

Bhandari NJ, Jain T, Marolda C, ZuWallack RL.

J Cardiopulm Rehabil Prev. 2013 Mar-Apr;33(2):123-7. doi: 10.1097/HCR.0b013e31828254d4.

PMID:
23399845
20.

Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.

Zuwallack RL, Nici L.

COPD. 2012 Dec;9(6):637-48. doi: 10.3109/15412555.2012.710668. Epub 2012 Sep 7. Review.

PMID:
22958136
21.

How do we increase activity and participation in our patients?

Zuwallack RL.

Semin Respir Crit Care Med. 2009 Dec;30(6):708-12. doi: 10.1055/s-0029-1242640. Epub 2009 Nov 25. Review.

PMID:
19941228
23.

Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease.

ZuWallack RL, Haggerty MC, Jones P.

Am J Med. 2004 Dec 20;117 Suppl 12A:49S-59S. Review.

PMID:
15693643
24.

The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma.

Carranza Rosenzweig JR, Edwards L, Lincourt W, Dorinsky P, ZuWallack RL.

Respir Med. 2004 Dec;98(12):1157-65.

25.

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL.

Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051.

PMID:
15264997
26.

Functional status and survival in COPD.

ZuWallack RL.

Monaldi Arch Chest Dis. 2003 Jul-Sep;59(3):230-3.

PMID:
15065323
27.

An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation.

Normandin EA, McCusker C, Connors M, Vale F, Gerardi D, ZuWallack RL.

Chest. 2002 Apr;121(4):1085-91.

PMID:
11948036
28.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

29.

Salmeterol plus theophylline combination therapy in the treatment of COPD.

ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K.

Chest. 2001 Jun;119(6):1661-70.

PMID:
11399688
30.

Functional status and survival following pulmonary rehabilitation.

Bowen JB, Votto JJ, Thrall RS, Haggerty MC, Stockdale-Woolley R, Bandyopadhyay T, ZuWallack RL.

Chest. 2000 Sep;118(3):697-703.

PMID:
10988191
31.

Long-term benefits of short-stay inpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease.

Bowen JB, Thrall RS, ZuWallack RL, Votto JJ.

Monaldi Arch Chest Dis. 1999 Apr;54(2):189-92.

PMID:
10394839
32.

The influence of demographic and socioeconomic factors on health-related quality of life in asthma.

Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL.

J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):72-8.

PMID:
9893188
33.

Selection criteria and outcome assessment in pulmonary rehabilitation.

ZuWallack RL.

Monaldi Arch Chest Dis. 1998 Aug;53(4):429-37. Review. No abstract available.

PMID:
9828600
34.

Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences.

Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL.

Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1810-7.

PMID:
9620910
35.

COPD and other diseases in chronically ventilated patients in a prolonged respiratory care unit: a retrospective 20-year survival study.

Votto J, Brancifort JM, Scalise PJ, Wollschlager CM, ZuWallack RL.

Chest. 1998 Jan;113(1):86-90.

PMID:
9440573
36.

Demographic predictors of asthma treatment site: outpatient, inpatient, or emergency department.

Apter AJ, Reisine ST, Kennedy DG, Cromley EK, Keener J, ZuWallack RL.

Ann Allergy Asthma Immunol. 1997 Oct;79(4):353-61.

PMID:
9357383
37.

Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood.

Apter AJ, Affleck G, Reisine ST, Tennen HA, Barrows E, Wells M, Willard A, ZuWallack RL.

J Allergy Clin Immunol. 1997 May;99(5):605-12.

PMID:
9155825
38.

The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.

ZuWallack RL, Rosen JP, Cohen L, Rachelefsky GS, Gong H Jr, Goldsobel AB, Kaliner MA, White MV, Bronsky EA, Chervinsky P, Lotner GZ, Corren J, Bodenheimer S.

J Allergy Clin Immunol. 1997 Mar;99(3):278-85.

PMID:
9058681
39.

Alterations in total and regional body composition in patients with moderate to severe obstructive lung disease.

ZuWallack RL, Shoup R, Warner S, Davies M, Khan F, Dalsky G.

Monaldi Arch Chest Dis. 1996 Dec;51(6):507-9. No abstract available.

PMID:
9046164
40.

The effect of inhaled albuterol in moderate to severe asthma.

Apter AJ, Reisine ST, Willard A, Clive J, Wells M, Metersky M, McNally D, ZuWallack RL.

J Allergy Clin Immunol. 1996 Aug;98(2):295-301.

PMID:
8757206
41.

Variables related to increased mortality following out-patient pulmonary rehabilitation.

Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL.

Eur Respir J. 1996 Mar;9(3):431-5.

42.

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.

Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.

Am J Med. 1996 Jan 29;100(1A):40S-48S.

PMID:
8610716
43.

A comparison of outpatient cardiac and pulmonary rehabilitation patients.

Reardon JZ, Levine S, Peske G, Elnaggar A, Normandin E, Clark B, ZuWallack RL.

J Cardiopulm Rehabil. 1995 Jul-Aug;15(4):277-82.

PMID:
8542533
44.

Common measures of asthma severity lack association for describing its clinical course.

Apter AJ, ZuWallack RL, Clive J.

J Allergy Clin Immunol. 1994 Oct;94(4):732-7.

PMID:
7930307
45.

The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea.

Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack RL.

Chest. 1994 Apr;105(4):1046-52.

PMID:
8162723
46.

The influence of spring and summer New England meteorologic conditions on the respiratory status of patients with chronic lung disease.

Mann M, Patel K, Reardon JZ, Goldstein M, Godar TJ, ZuWallack RL.

Chest. 1993 May;103(5):1369-74.

PMID:
8486012
47.
48.

An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone.

Mann MC, Eliasson O, Patel K, ZuWallack RL.

Chest. 1992 Nov;102(5):1342-6.

PMID:
1424848
49.

A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide.

Mann M, Eliasson O, Patel K, ZuWallack RL.

Chest. 1992 Feb;101(2):496-9.

PMID:
1735279
50.

Bronchial hyperresponsiveness in asthma: its significance and therapy.

Zuwallack RL.

Conn Med. 1990 Nov;54(11):607-13. Review. No abstract available.

PMID:
2261766

Supplemental Content

Loading ...
Support Center